Partial Seizures
📧 Sign up to get email alerts when something new happens for Partial Seizures.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-05-22Clinical Trial Update: RNS System RESPONSE Study [NA]
The NeuroPace RNS System RESPONSE study was terminated during its course.
-
CLINICAL_TRIALS trial_result · 2024-07-23Clinical Trial Update: A Study of Levetiracetam as Monotherapy or Adjunctive Treatment of Partial Seizures in Pediatric Epileptic Subjects Ranging From 1 Month to Less Than 4 Years of Age [Phase 3]
Phase 3 trial evaluating levetiracetam as monotherapy or adjunctive therapy for partial seizures in children aged 1 month to less than 4 yea…
-
CLINICAL_TRIALS trial_result · 2021-04-27Clinical Trial Update: Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy [Phase 2]
Phase 2 trial investigating natalizumab for focal epilepsy has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-01-25Clinical Trial Update: Pregabalin In Partial Seizures: An Open-Label, International, Multicenter Add-On Therapy Trial. [Phase 4]
An open-label, Phase 4 trial of pregabalin as add-on therapy for partial seizures was completed.
-
CLINICAL_TRIALS trial_result · 2021-01-22Clinical Trial Update: Pregabalin Epilepsy Add-On Trial [Phase 3]
Phase 3 trial update for pregabalin as add-on therapy in partial seizures has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-08-19Clinical Trial Update: Open Label Safety and Efficacy Study of Levetiracetam in Patients With Epilepsy [Phase 4]
Phase 4 open-label safety and efficacy study of levetiracetam in epilepsy (partial seizures) completed; results posted.
-
CLINICAL_TRIALS trial_result · 2020-02-21Clinical Trial Update: A 12-Month Study To Evaluate The Safety And Tolerability Of Pregabalin As Add-On Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-Clonic Seizures [Phase 3]
A Phase 3 study evaluating the safety and tolerability of pregabalin as add-on therapy in pediatric and adult subjects with partial onset se…
-
CLINICAL_TRIALS trial_result · 2019-06-10Clinical Trial Update: Follow-up Study of L059 (Levetiracetam) in Epileptic Patients With Partial Onset Seizures by Open Label Method [Phase 3]
Phase 3 follow-up open-label study of levetiracetam for partial-onset seizures in epilepsy; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2018-08-29Clinical Trial Update: A Long-term Extension Study of E2007 in Patients With Refractory Partial Seizures Uncontrolled With Other Anti-Epileptic Drugs (AEDs) [Phase 2]
Long-term extension study of E2007 in patients with refractory partial seizures completed; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-06-06Clinical Trial Update: Once-A-Day Pregabalin For Partial Seizures [Phase 3]
Phase 3 trial update for once-daily pregabalin in partial seizures has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-07-12Clinical Trial Update: Sabril for Complex Partial Seizures in Adult Tolerability Study (TS) Patients [Phase 4]
A Phase 4 tolerability study of vigabatrin (Sabril) for complex partial seizures was terminated; results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-05-11Clinical Trial Update: Remegal Different Doses in Patients With Refractory Partial Seizures [Phase 2]
Phase 2 trial evaluating different doses of Remegal in patients with refractory partial seizures has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-11Clinical Trial Update: Remegal Fixed Dose as Adjunctive Therapy in Patients With Partial Seizures [Phase 3]
A Phase 3 trial of Remegal fixed-dose as adjunctive therapy for partial seizures has completed under sponsor Valexfarm.
-
CLINICAL_TRIALS trial_result · 2017-03-21Clinical Trial Update: A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years [Phase 3]
Phase 3 trial evaluating pregabalin as add-on therapy for partial onset seizures in children aged 4-16; completed with results posted in 201…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Efficacy, Safety, and Tolerability of Oxcarbazepine Monotherapy in Children With Partial Seizures [Phase 4]
Phase 4 trial in children with partial seizures assessed the efficacy, safety, and tolerability of oxcarbazepine monotherapy.
-
CLINICAL_TRIALS trial_result · 2016-10-31Clinical Trial Update: Efficacy and Safety of Levetiracetam in Partial Seizures Control, With or Without Secondary Generalization [Phase 3]
A Phase 3 clinical trial evaluating the efficacy and safety of levetiracetam for controlling partial seizures, with or without secondary gen…
-
CLINICAL_TRIALS trial_result · 2016-08-16Clinical Trial Update: Efficacy and Safety of Diazepam in the Management of Refractory Epilepsy in Selected Patients Who Require Intermittent Medical Intervention for Acute Repetitive Seizures. [Phase 3]
Phase 3 trial evaluating diazepam for management of refractory epilepsy in patients requiring intermittent medical intervention for acute re…
-
CLINICAL_TRIALS trial_result · 2015-03-05Clinical Trial Update: Evaluation of Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures. [Phase 3]
This Clinical Trial Update reports the completion of a Phase 3 study evaluating long-term safety and efficacy of pregabalin in patients with…
-
CLINICAL_TRIALS trial_result · 2014-09-22Clinical Trial Update: Safety and Tolerability of Intravenous SPM 927 as Replacement for Oral SPM 927 in Subjects With Partial Seizures [Phase 2, Phase 3]
This clinical trial update reports on the safety and tolerability of intravenous SPM 927 as a replacement for oral SPM 927 in subjects with …
-
CLINICAL_TRIALS trial_result · 2014-09-22Clinical Trial Update: SPM 927 (400mg/Day and 600mg/Day) as Adjunctive Therapy in Subjects With Partial Seizures With or Without Secondary Generalization [Phase 3]
A Phase 3 trial evaluating SPM 927 as adjunctive therapy for partial seizures (with or without secondary generalization) completed, sponsore…
-
CLINICAL_TRIALS trial_result · 2014-08-15Clinical Trial Update: Evaluating the Efficacy and Safety of Zonisamide in the Treatment of Partial Seizures [Phase 3]
Phase 3 trial update evaluating the efficacy and safety of zonisamide for partial seizures. Results have been posted.
-
CLINICAL_TRIALS trial_result · 2014-07-18Clinical Trial Update: Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients [Phase 3]
This update reports the completion of a Phase 3 trial evaluating eslicarbazepine acetate as add-on therapy for partial seizures in elderly p…
-
CLINICAL_TRIALS trial_result · 2014-07-14Clinical Trial Update: Evaluation of the Efficacy and Safety of Adjunctive Zonisamide vs Replacement With Zonisamide of the Last Added Antiepileptic Drug [Phase 4]
Phase 4 trial evaluated whether continuing zonisamide as adjunctive therapy is more effective or safer than replacing the last added antiepi…
-
CLINICAL_TRIALS trial_result · 2013-07-11Clinical Trial Update: Pregabalin Versus Levetiracetam In Partial Seizures [Phase 3]
Phase 3 trial comparing pregabalin to levetiracetam in partial seizures has completed with results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-02-07Clinical Trial Update: An add-on Study of E2007 in Patients With Refractory Partial Seizures Uncontrolled With Other Anti-epileptic Drugs (AEDs) [Phase 2]
Phase 2 add-on study of E2007 in patients with refractory partial seizures uncontrolled with other anti-epileptic drugs has completed enroll…